Sam Tomioka

Sam Tomioka currently serves as the Executive Director, Head of Computational Research and Analytics at Sumitomo Pharma America, Inc., leading a multidisciplinary team focused on Bioinformatics, AI for Knowledge Discovery, Real-World Evidence/Epidemiology, Clinical Analytics, and Data Science. With extensive experience across various roles in the pharmaceutical sector, including positions at Sunovion Pharmaceuticals and Dainippon Sumitomo Pharma, Sam has a proven track record in optimizing clinical trial execution through advanced analytics. In addition to a longstanding involvement with the US-Japan Health Care Study Group, contributions to the PhUSE and CDISC initiatives demonstrate a commitment to advancing data standards and methodologies. Sam holds certificates in Data Analysis for Life Sciences from Harvard University and Data Science from The Johns Hopkins University, as well as a Master of Science from the University of Canterbury and a Bachelor of Science from the University of South Carolina Upstate.